中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

非小细胞肺癌术中淋巴结清扫方式的研究进展

查看全文

非小细胞肺癌淋巴结转移是预后不良的独立危险因素,而切除淋巴结可改善患者预后,尽管外科技术在不断进步,对非小细胞肺癌淋巴结切除方式仍存在较大争议,本文就目前非小细胞肺癌淋巴结切除方式的选择等热点问题的研究进展进行讨论和总结。

Lymph node metastasis in non-small cell lung cancer is an independent risk factor for poor prognosis. Resection of lymph nodes can improve the prognosis of patients. Although surgical techniques are progressing, there is still much controversy about the way of lymph node resection for non-small cell lung cancer. The research progress of hotspots such as the choice of lymph node resection methods for cell lung cancer is discussed and summarized.

关键词: 非小细胞肺癌; 系统性淋巴结清扫; 采样; 叶特异性淋巴结清扫

Key words: non-small cell lung cancer; systemic lymph node dissection; sampling; leaf-specific lymph node dissection

登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Rami-Porta R, Asamura H, Travis WD, et al. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin, 2017, 67(2): 138-155.
2. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg, 2006, 30(5): 787-792.
3. Hughes MJ, Chowdhry MF, Woolley SM, et al., In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior? Interact Cardiovasc Thorac Surg, 2011, 13(3): 311-315.
4. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg, 1998, 22(3): 290-294.
5. Okada M, Sakamoto T, Yuki T, et al. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg, 2006, 81(3): 1028-1032.
6. Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg, 1999, 117(6): 1102-1111.
7. Aokage K, Yoshida J, Ishii G, et al. Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? Lung Cancer, 2010, 70(2): 163-167.
8. Watanabe S, Asamura H, Suzuki K, et al. The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg, 2005, 4(2): 106-109.
9. Okada M, Tsubota N, Yoshimura M, et al. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg, 1998, 116(6): 949-953.
10. Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer, 2002, 36(1): 1-6.
11. Ma K, Chang D, He B, et al. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer. J Cancer Res Clin Oncol, 2008, 134(12): 1289-1295.
12. Donington JS, Blasberg JD. Management of early stage non-small cell lung cancer in high-risk patients. Thorac Surg Clin, 2012, 22(1): 55-65.
13.